JUST IN: Poisons Board Quarantines Injection Drug Due to Quality Concerns
The Pharmacy and Poisons Board (PPB) has ordered the immediate quarantine of Flurasted 500 (5-Fluorouracil) Injection, Batch No. HHP24017, which is used in cancer treatment. This action follows complaints regarding the drug’s appearance. In a statement issued on Thursday, December 5, PPB explained that the quarantine order was prompted by concerns over the visual quality of the batch. “The Pharmacy and Poisons Board has ordered the quarantine of Flurasted 500 (5-Fluorouracil) Injection, Batch No. HHP24017, manufactured by Halsted Pharma Private Limited, India,” the statement confirmed. PPB CEO Fred Siyoi directed all pharmaceutical outlets and healthcare facilities to immediately quarantine the
The post Poisons Board Quarantines Injection Drug Due to Quality Concerns appeared first on Nairobi Wire. Read More
